067370 — Sun Bio Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual income statement for Sun Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	9,965	7,420	12,292	8,683	13,673
Cost of Revenue
Gross Profit	6,728	4,514	8,636	5,921	8,340
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	6,588	7,229	7,100	9,216	8,636
Operating Profit	3,377	191	5,192	-533	5,036
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,133	937	5,550	-227	2,875
Provision for Income Taxes
Net Income After Taxes	285	869	4,607	-104	2,793
Net Income Before Extraordinary Items
Net Income	285	869	4,607	-104	2,793
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	285	869	4,607	-104	2,793
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	24.5	72.6	374	-8.48	241
Dividends per Share